Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alexei V. Trofimov, Ph.D.

Co-Author

This page shows the publications co-authored by Alexei Trofimov and Jason Efstathiou.
Connection Strength

1.647
  1. Characterization of an Iodinated Rectal Spacer for Prostate Photon and Proton Radiation Therapy. Pract Radiat Oncol. 2022 Mar-Apr; 12(2):135-144.
    View in: PubMed
    Score: 0.241
  2. Proton vs. photon radiotherapy for MR-guided dose escalation of intraprostatic lesions. Acta Oncol. 2021 Oct; 60(10):1283-1290.
    View in: PubMed
    Score: 0.237
  3. Hypofractionated proton therapy for prostate cancer: dose delivery uncertainty due to interfractional motion. Med Phys. 2013 Jul; 40(7):071714.
    View in: PubMed
    Score: 0.136
  4. Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions. Med Phys. 2013 May; 40(5):051708.
    View in: PubMed
    Score: 0.134
  5. Clinical controversies: proton therapy for prostate cancer. Semin Radiat Oncol. 2013 Apr; 23(2):109-14.
    View in: PubMed
    Score: 0.133
  6. Evaluation of the dosimetric impact of interfractional anatomical variations on prostate proton therapy using daily in-room CT images. Med Phys. 2011 Aug; 38(8):4623-33.
    View in: PubMed
    Score: 0.119
  7. Evaluation of the dosimetric impact of interfractional anatomical variations on prostate proton therapy using daily in-room CT images. Med Phys. 2011 Aug; 38(8):4623-4633.
    View in: PubMed
    Score: 0.119
  8. Interfractional variations in the setup of pelvic bony anatomy and soft tissue, and their implications on the delivery of proton therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2011 Jul 01; 80(3):928-37.
    View in: PubMed
    Score: 0.112
  9. Life, liberty, and the pursuit of protons: an evidence-based review of the role of particle therapy in the treatment of prostate cancer. Cancer J. 2009 Jul-Aug; 15(4):312-8.
    View in: PubMed
    Score: 0.103
  10. Impact of interfractional motion on hypofractionated pencil beam scanning proton therapy and VMAT delivery for prostate cancer. Med Phys. 2018 Jul 14.
    View in: PubMed
    Score: 0.048
  11. Proton therapy of prostate cancer by anterior-oblique beams: implications of setup and anatomy variations. Phys Med Biol. 2017 03 07; 62(5):1644-1660.
    View in: PubMed
    Score: 0.044
  12. SU-G-JeP4-09: Impact of Interfractional Motion On Hypofractionated Pencil Beam Scanning Proton Therapy for Prostate Cancer. Med Phys. 2016 Jun; 43(6):3683.
    View in: PubMed
    Score: 0.042
  13. A Prospective Comparison of the Effects of Interfractional Variations on Proton Therapy and Intensity Modulated Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):444-453.
    View in: PubMed
    Score: 0.040
  14. SU-E-T-457: Impact of Interfractional Variations On Anterior Vs. Lateral-Field Proton Therapy of Prostate Cancer. Med Phys. 2015 Jun; 42(6):3439.
    View in: PubMed
    Score: 0.039
  15. Validation of a deformable image registration technique for cone beam CT-based dose verification. Med Phys. 2015 Jan; 42(1):196-205.
    View in: PubMed
    Score: 0.038
  16. SU-E-T-616: Comparison of Plan Dose Accuracy for Anterior Vs. Lateral Fields in Proton Therapy of Prostate Cancer. Med Phys. 2014 Jun; 41(6):369.
    View in: PubMed
    Score: 0.036
  17. Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trial. Int J Radiat Oncol Biol Phys. 2010 Nov 15; 78(4):1081-5.
    View in: PubMed
    Score: 0.027
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.